HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael J Mitten Selected Research
Michael J Mitten Research Topics
Disease
17
Neoplasms (Cancer)
04/2021 - 06/2005
4
Glioblastoma (Glioblastoma Multiforme)
04/2021 - 01/2016
4
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2014 - 06/2005
3
Lymphoma (Lymphomas)
02/2013 - 06/2005
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2015 - 02/2013
2
Multiple Myeloma
10/2010 - 05/2008
2
B-Cell Lymphoma (Lymphoma, B Cell)
10/2010 - 05/2008
1
Malignant Mesothelioma
10/2020
1
Hypoxia (Hypoxemia)
09/2017
1
Neutropenia
03/2015
1
Thrombocytopenia (Thrombopenia)
10/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2010
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2010
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2008
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008
1
Weight Loss (Weight Reduction)
06/2005
1
Infections
01/2004
Drug/Important Bio-Agent (IBA)
7
navitoclax
IBA
03/2015 - 05/2008
4
Immunoconjugates (Immunoconjugate)
IBA
04/2021 - 01/2016
4
Proteins (Proteins, Gene)
FDA Link
02/2013 - 06/2005
3
depatuxizumab mafodotin
IBA
04/2021 - 01/2018
2
Temozolomide (Temodar)
FDA Link
Generic
04/2021 - 01/2016
2
epidermal growth factor receptor VIII
IBA
04/2021 - 01/2016
2
Epitopes
IBA
01/2018 - 01/2016
2
depatuxizumab
IBA
01/2018 - 01/2016
2
venetoclax
IBA
03/2015 - 02/2013
2
Sirolimus (Rapamycin)
FDA Link
10/2008 - 06/2005
1
Biomarkers (Surrogate Marker)
IBA
04/2021
1
ErbB Receptors (EGF Receptor)
IBA
04/2021
1
Antigens
IBA
04/2021
1
A-1331852
IBA
10/2020
1
auristatin
IBA
10/2020
1
monomethyl auristatin E
IBA
01/2018
1
monomethylauristatin F
IBA
01/2018
1
Interleukins
IBA
09/2017
1
Cisplatin (Platino)
FDA Link
Generic
01/2017
1
ABT-414
IBA
01/2016
1
Docetaxel (Taxotere)
FDA Link
03/2015
1
A-1155463
IBA
10/2014
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2010
1
Rituximab (Mabthera)
FDA Link
10/2010
1
Bortezomib (Velcade)
FDA Link
10/2010
1
Vincristine (Oncovin)
FDA Link
Generic
10/2010
1
Cytotoxins (Cytolysins)
IBA
10/2010
1
Etoposide (VP 16)
FDA Link
Generic
10/2010
1
Caspase 3 (Caspase-3)
IBA
10/2008
1
Cytostatic Agents
IBA
10/2008
1
Cytochromes c (Cytochrome c)
IBA
05/2008
1
ABT-737
IBA
06/2005
1
Paclitaxel (Taxol)
FDA Link
Generic
06/2005
1
Phosphotransferases (Kinase)
IBA
06/2005
1
Glucose (Dextrose)
FDA Link
Generic
06/2005
1
N- succinimidyl- 4- ((iodoacetyl)amino)benzoate
IBA
01/2004
Therapy/Procedure
8
Therapeutics
01/2018 - 06/2005
1
Aftercare (After-Treatment)
04/2021
1
Withholding Treatment
06/2008
1
Oral Administration
05/2008